300 related articles for article (PubMed ID: 34011685)
1. Primed CRISPR-Cas Adaptation and Impaired Phage Adsorption in Streptococcus mutans.
Mosterd C; Moineau S
mSphere; 2021 May; 6(3):. PubMed ID: 34011685
[No Abstract] [Full Text] [Related]
2. Characterization of a Type II-A CRISPR-Cas System in
Mosterd C; Moineau S
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581075
[No Abstract] [Full Text] [Related]
3. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
[TBL] [Abstract][Full Text] [Related]
4. Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages.
van der Ploeg JR
Microbiology (Reading); 2009 Jun; 155(Pt 6):1966-1976. PubMed ID: 19383692
[TBL] [Abstract][Full Text] [Related]
5. Imprecise Spacer Acquisition Generates CRISPR-Cas Immune Diversity through Primed Adaptation.
Jackson SA; Birkholz N; Malone LM; Fineran PC
Cell Host Microbe; 2019 Feb; 25(2):250-260.e4. PubMed ID: 30661951
[TBL] [Abstract][Full Text] [Related]
6. Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology.
Serbanescu MA; Cordova M; Krastel K; Flick R; Beloglazova N; Latos A; Yakunin AF; Senadheera DB; Cvitkovitch DG
J Bacteriol; 2015 Feb; 197(4):749-61. PubMed ID: 25488301
[TBL] [Abstract][Full Text] [Related]
7. Avoidance of Trinucleotide Corresponding to Consensus Protospacer Adjacent Motif Controls the Efficiency of Prespacer Selection during Primed Adaptation.
Musharova O; Vyhovskyi D; Medvedeva S; Guzina J; Zhitnyuk Y; Djordjevic M; Severinov K; Savitskaya E
mBio; 2018 Dec; 9(6):. PubMed ID: 30514784
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systems.
Nicholson TJ; Jackson SA; Croft BI; Staals RHJ; Fineran PC; Brown CM
RNA Biol; 2019 Apr; 16(4):566-576. PubMed ID: 30157725
[TBL] [Abstract][Full Text] [Related]
9. Identification of Spacer and Protospacer Sequence Requirements in the Vibrio cholerae Type I-E CRISPR/Cas System.
Bourgeois J; Lazinski DW; Camilli A
mSphere; 2020 Nov; 5(6):. PubMed ID: 33208517
[TBL] [Abstract][Full Text] [Related]
10. Characterization of CRISPR-Cas systems in the Ralstonia solanacearum species complex.
da Silva Xavier A; de Almeida JCF; de Melo AG; Rousseau GM; Tremblay DM; de Rezende RR; Moineau S; Alfenas-Zerbini P
Mol Plant Pathol; 2019 Feb; 20(2):223-239. PubMed ID: 30251378
[TBL] [Abstract][Full Text] [Related]
11. The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity.
Levin BR; Moineau S; Bushman M; Barrangou R
PLoS Genet; 2013; 9(3):e1003312. PubMed ID: 23516369
[TBL] [Abstract][Full Text] [Related]
12. Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers.
Watson BNJ; Easingwood RA; Tong B; Wolf M; Salmond GPC; Staals RHJ; Bostina M; Fineran PC
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180090. PubMed ID: 30905290
[TBL] [Abstract][Full Text] [Related]
13. CRISPR analysis of bacteriophage-insensitive mutants (BIMs) of industrial Streptococcus thermophilus--implications for starter design.
Mills S; Griffin C; Coffey A; Meijer WC; Hafkamp B; Ross RP
J Appl Microbiol; 2010 Mar; 108(3):945-955. PubMed ID: 19709335
[TBL] [Abstract][Full Text] [Related]
14. Biology and genome sequence of Streptococcus mutans phage M102AD.
Delisle AL; Guo M; Chalmers NI; Barcak GJ; Rousseau GM; Moineau S
Appl Environ Microbiol; 2012 Apr; 78(7):2264-71. PubMed ID: 22287009
[TBL] [Abstract][Full Text] [Related]
15. Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.
Heussler GE; Miller JL; Price CE; Collins AJ; O'Toole GA
J Bacteriol; 2016 Nov; 198(22):3080-3090. PubMed ID: 27573013
[TBL] [Abstract][Full Text] [Related]
16. Procedures for Generating CRISPR Mutants with Novel Spacers Acquired from Viruses or Plasmids.
Dupuis MÈ; Barrangou R; Moineau S
Methods Mol Biol; 2015; 1311():195-222. PubMed ID: 25981475
[TBL] [Abstract][Full Text] [Related]
17. Spacer Acquisition Rates Determine the Immunological Diversity of the Type II CRISPR-Cas Immune Response.
Heler R; Wright AV; Vucelja M; Doudna JA; Marraffini LA
Cell Host Microbe; 2019 Feb; 25(2):242-249.e3. PubMed ID: 30709780
[TBL] [Abstract][Full Text] [Related]
18. Cas9 Cleavage of Viral Genomes Primes the Acquisition of New Immunological Memories.
Nussenzweig PM; McGinn J; Marraffini LA
Cell Host Microbe; 2019 Oct; 26(4):515-526.e6. PubMed ID: 31585845
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CRISPR Spacer and Protospacer Sequences in
Stamereilers C; Wong S; Tsourkas PK
Viruses; 2021 Mar; 13(3):. PubMed ID: 33799666
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas provides limited phage immunity to a prevalent gut bacterium in gnotobiotic mice.
Rasmussen TS; Koefoed AK; Deng L; Muhammed MK; Rousseau GM; Kot W; Sprotte S; Neve H; Franz CMAP; Hansen AK; Vogensen FK; Moineau S; Nielsen DS
ISME J; 2023 Mar; 17(3):432-442. PubMed ID: 36631688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
